All Ords cracks 9,000 points as ASX closes the week higher — as it happened
Australian Broadcasting Corporationarrow_outwardASX has best week since May
News.com.auarrow_outwardBHP, CSL, banks, Wesfarmers, Goodman lift ASX 200 to record high; Mesoblast top gainer
The Australianarrow_outwardBHP boosts ASX to record high; Mesoblast rockets 35 per cent - The Sydney Morning Herald
The Sydney Morning Heraldarrow_outwardJefferies downgrades Mesoblast stock to Hold despite price target increase - Investing.com
Investing.comarrow_outwardMesoblast shares soar 35pc on strong cell therapy sales data - AFR
AFRarrow_outwardASX surges to record close; Mesoblast rips on flagship sales performance - Capital Brief
Capital Briefarrow_outwardASX 200 live: BHP in focus; Virgin lifts on broker optimism; Mesoblast top gainer; Fletcher's outlook warning - Gold Coast Bulletin
Gold Coast Bulletinarrow_outwardWhy BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher - The Motley Fool Australia
The Motley Fool Australiaarrow_outwardASX smashes 8700 as BHP, Mesoblast soar - The Courier Mail
The Courier Mailarrow_outwardLunch Wrap: ASX smashes 8700 for first time as BHP crushes records, Mesoblast soars - The Mercury
The Mercuryarrow_outwardMesoblast (ASX:MSB) share price soars after exciting June quarter update - Rask Media
Rask Mediaarrow_outwardSuccessful Commercial Launch of Ryoncil® - The Manila Times
The Manila Timesarrow_outwardMesoblast's Groundbreaking GVHD Drug Ryoncil Hits $13.2M in First Quarter Sales After FDA Approval - Stock Titan
Stock Titanarrow_outwardJPMorgan Acquires 5% Stake in Mesoblast Limited - TipRanks
TipRanksarrow_outwardAnterior Cruciate Ligament Injuries Market Forecast 2032: - openPR.com
OpenPR.comarrow_outwardInsider Stock Buying Reaches US$201.4m On Mesoblast - simplywall.st
Simplywall.starrow_outwardMesoblast: A Cautionary Hold On Regenerative Medicine's Risky Edge (Upgrade) - Seeking Alpha
Seeking Alphaarrow_outwardMesoblast Shares Surge on FDA Alignment - Sharecafe
Sharecafearrow_outwardMesoblast (MESO) Gains After FDA Supports BLA Application Plans - GuruFocus
GuruFocusarrow_outwardMesoblast Algins With FDA on Biologic License Application for Heart Failure Treatment - MarketScreener
MarketScreenerarrow_outwardMesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday - Benzinga
Benzingaarrow_outwardMesoblast's Revascor®: A Pivotal Moment in Regenerative Medicine Leadership - AInvest
AInvestarrow_outwardMesoblast (MESO) Gets 7 Years of Orphan-drug Exclusive Approval from US FDA for Ryoncil - Yahoo Finance
Yahoo Financearrow_outwardJPMorgan Becomes Substantial Holder in Mesoblast - MSN
MSNarrow_outwardKalkine: ASX 200 Biotech Firm Mesoblast Gains Momentum Following FDA Developments - Kalkine Media
Kalkine Mediaarrow_outwardDr Boreham's Crucible: Can this biotech emerge from Mesoblast's shadow and ride 'stem cells 2.0'? - Stockhead
Stockheadarrow_outwardMesoblast's FDA Tick of Approval - intelligentinvestor.com.au
Intelligentinvestor.com.auarrow_outwardMesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives - TradingView
TradingViewarrow_outwardMesoblast says its FDA-approved mesenchymal stromal cell therapy available for sale in the US - Biotech Dispatch
Biotech Dispatcharrow_outwardMesoblast says study of remestemcel-L in COVID-19-related ARDS unlikely to hit mortality goal - FirstWord Pharma
FirstWord Pharmaarrow_outwardMesoblast Limited (MESO): Among the Best Australian Stocks to Buy According to Billionaires - Insider Monkey
Insider Monkeyarrow_outwardMesoblast Joins S&P/ASX 200 Index - Finance News Network
Finance News Networkarrow_outwardMesoblast prices pediatric stem cell treatment at $1.55 million - BioWorld MedTech
BioWorld MedTecharrow_outwardStocks making the biggest moves at noon: Telix, Mesoblast, Uranium and more - Market Index
Market Indexarrow_outwardMesoblast prepares to launch FDA-approved therapy for Pediatric Steroid-Refractory aGVHD - Proactive financial news
Proactive financial newsarrow_outwardZip Co, Mesoblast among ASX's best performers in 2024 - Shepparton News
Shepparton Newsarrow_outwardAfter two rejections, FDA approves Mesoblast's first-of-its-kind cell therapy - Fierce Pharma
Fierce Pharmaarrow_outwardStem-cell treatment gets breakthrough FDA approval - Herald Sun
Herald Sunarrow_outward10-bagger Mesoblast secures FDA approval for RYONCIL® as first MSC therapy in the US - Proactive Investors
Proactive Investorsarrow_outwardFDA Approves Mesoblast’s Remestemcel-L for Steroid-Refractory GvHD - CGTLive®
CGTLive®arrow_outwardMesoblast class action settlement wins court OK - Lawyerly
Lawyerlyarrow_outwardMesoblast drug gets approval from FDA, but shares drop - Australian Manufacturing Forum
Australian Manufacturing Forumarrow_outward
Mesoblast close
- 2025-07-18 16:30 event
- 43 sourceslanguage
- 200+ ads_click
- 1 month ago schedule